AA

Anita Antony Kattukaran

Active Director Director DIN 00136652
DIN 00136652 First appointment May 2006 Primary industry Education
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2006
Shareholding value β€’β€’β€’β€’ Premium profile

About Anita Antony Kattukaran

Data last updated:

Anita Antony Kattukaran is a Director at Inter-Ed Faculty Of Clinical Research India (Ifcr) Private Limited (since 2006). The company operates in Education.

DIN 00136652
Primary Designation Director
Industry Education
First Appointment 23 May 2006
Oldest Company Age 20 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 May 20062006Active

Directorship timeline

Open interactive timeline →
Inter-Ed Faculty Of Clinical Research India (Ifcr) Private Limited
Premium access

Shareholding and investment profile for Anita Antony Kattukaran

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anita Antony Kattukaran

Anita Antony Kattukaran currently holds 1 directorship: Inter-Ed Faculty Of Clinical Research India (Ifcr) Private Limited (Director, since 23 May 2006).

Anita Antony Kattukaran was first appointed on 23 May 2006 as Director at Inter-Ed Faculty Of Clinical Research India (Ifcr) Private Limited.

The current boards of Anita Antony Kattukaran's companies include Anil Joseph (Inter-Ed Faculty Of Clinical Research India (Ifcr) Private Limited), Sunil Joseph (Inter-Ed Faculty Of Clinical Research India (Ifcr) Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available